PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MNMD vs. NVDA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


MNMDNVDA
YTD Return112.02%186.76%
1Y Return215.45%187.03%
3Y Return (Ann)-39.70%67.84%
Sharpe Ratio2.133.68
Sortino Ratio3.063.78
Omega Ratio1.351.49
Calmar Ratio2.077.04
Martin Ratio6.5322.20
Ulcer Index30.55%8.58%
Daily Std Dev93.74%51.84%
Max Drawdown-96.96%-89.73%
Current Drawdown-88.97%-4.63%

Fundamentals


MNMDNVDA
Market Cap$600.59M$3.64T
EPS-$2.04$2.18
Total Revenue (TTM)$4.84M$78.19B
Gross Profit (TTM)$3.52M$59.77B
EBITDA (TTM)-$92.34M$52.02B

Correlation

-0.50.00.51.00.3

The correlation between MNMD and NVDA is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

MNMD vs. NVDA - Performance Comparison

In the year-to-date period, MNMD achieves a 112.02% return, which is significantly lower than NVDA's 186.76% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%60.00%JuneJulyAugustSeptemberOctoberNovember
-5.60%
53.55%
MNMD
NVDA

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MNMD vs. NVDA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Mind Medicine (MindMed) Inc. (MNMD) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MNMD
Sharpe ratio
The chart of Sharpe ratio for MNMD, currently valued at 2.13, compared to the broader market-4.00-2.000.002.002.13
Sortino ratio
The chart of Sortino ratio for MNMD, currently valued at 3.06, compared to the broader market-4.00-2.000.002.004.003.06
Omega ratio
The chart of Omega ratio for MNMD, currently valued at 1.35, compared to the broader market0.501.001.502.001.35
Calmar ratio
The chart of Calmar ratio for MNMD, currently valued at 2.07, compared to the broader market0.002.004.006.002.07
Martin ratio
The chart of Martin ratio for MNMD, currently valued at 6.53, compared to the broader market0.0010.0020.0030.006.53
NVDA
Sharpe ratio
The chart of Sharpe ratio for NVDA, currently valued at 3.67, compared to the broader market-4.00-2.000.002.003.68
Sortino ratio
The chart of Sortino ratio for NVDA, currently valued at 3.78, compared to the broader market-4.00-2.000.002.004.003.78
Omega ratio
The chart of Omega ratio for NVDA, currently valued at 1.49, compared to the broader market0.501.001.502.001.49
Calmar ratio
The chart of Calmar ratio for NVDA, currently valued at 7.04, compared to the broader market0.002.004.006.007.04
Martin ratio
The chart of Martin ratio for NVDA, currently valued at 22.20, compared to the broader market0.0010.0020.0030.0022.20

MNMD vs. NVDA - Sharpe Ratio Comparison

The current MNMD Sharpe Ratio is 2.13, which is lower than the NVDA Sharpe Ratio of 3.68. The chart below compares the historical Sharpe Ratios of MNMD and NVDA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.00JuneJulyAugustSeptemberOctoberNovember
2.13
3.68
MNMD
NVDA

Dividends

MNMD vs. NVDA - Dividend Comparison

MNMD has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.


TTM20232022202120202019201820172016201520142013
MNMD
Mind Medicine (MindMed) Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVDA
NVIDIA Corporation
0.02%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%1.70%1.94%

Drawdowns

MNMD vs. NVDA - Drawdown Comparison

The maximum MNMD drawdown since its inception was -96.96%, which is greater than NVDA's maximum drawdown of -89.73%. Use the drawdown chart below to compare losses from any high point for MNMD and NVDA. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-88.97%
-4.63%
MNMD
NVDA

Volatility

MNMD vs. NVDA - Volatility Comparison

Mind Medicine (MindMed) Inc. (MNMD) has a higher volatility of 26.16% compared to NVIDIA Corporation (NVDA) at 10.50%. This indicates that MNMD's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%JuneJulyAugustSeptemberOctoberNovember
26.16%
10.50%
MNMD
NVDA

Financials

MNMD vs. NVDA - Financials Comparison

This section allows you to compare key financial metrics between Mind Medicine (MindMed) Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items